|
Volumn 76 Suppl 1, Issue , 2002, Pages 337-339
|
Early results of total therapy II in multiple myeloma: implications of cytogenetics and FISH.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
THALIDOMIDE;
AGED;
ARTICLE;
CHROMOSOME ABERRATION;
CHROMOSOME ANALYSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FLUORESCENCE IN SITU HYBRIDIZATION;
FOLLOW UP;
GENETICS;
HUMAN;
MIDDLE AGED;
MORTALITY;
MULTIPLE MYELOMA;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
TREATMENT OUTCOME;
AGED;
CHROMOSOME ABERRATIONS;
CYTOGENETIC ANALYSIS;
FOLLOW-UP STUDIES;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
MIDDLE AGED;
MULTIPLE MYELOMA;
PROGNOSIS;
SURVIVAL ANALYSIS;
THALIDOMIDE;
TREATMENT OUTCOME;
|
EID: 1842833290
PISSN: 09255710
EISSN: None
Source Type: Journal
DOI: 10.1007/BF03165280 Document Type: Article |
Times cited : (16)
|
References (0)
|